Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis
The investigation of therapeutic cancer vaccines has been ongoing for the past century. Herein, we used VOSviewer and CiteSpace to perform the first global bibliometric analysis of the literature on therapeutic cancer vaccines from 2013 to 2022 aiming to explore the current status and potential rese...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-08-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2023.2254262 |
| _version_ | 1827767365179277312 |
|---|---|
| author | Juan Zhao Bin Liao Li Gong Huiyao Yang Sha Li Yongsheng Li |
| author_facet | Juan Zhao Bin Liao Li Gong Huiyao Yang Sha Li Yongsheng Li |
| author_sort | Juan Zhao |
| collection | DOAJ |
| description | The investigation of therapeutic cancer vaccines has been ongoing for the past century. Herein, we used VOSviewer and CiteSpace to perform the first global bibliometric analysis of the literature on therapeutic cancer vaccines from 2013 to 2022 aiming to explore the current status and potential research trends. The findings revealed a consistent upward trend in both publication counts and citations. The United States emerged as the leading contributor with the highest number of published papers. Additionally, the analysis of references and keywords indicated that therapeutic cancer vaccines have long been popular topics, whereas neoantigen vaccines, mRNA vaccines, combination strategies, and vaccine delivery systems are emerging research hotspots. This bibliometric study provides a comprehensive and important overview of the current knowledge and potential developments in therapeutic cancer vaccines from 2013 to 2022, which may serve as a valuable reference for scholars interested in further exploring this promising field. |
| first_indexed | 2024-03-11T11:57:44Z |
| format | Article |
| id | doaj.art-596ddbac838b4fe3aee6bdc200ef1bf1 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T11:57:44Z |
| publishDate | 2023-08-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-596ddbac838b4fe3aee6bdc200ef1bf12023-11-08T11:55:20ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-08-0119210.1080/21645515.2023.22542622254262Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysisJuan Zhao0Bin Liao1Li Gong2Huiyao Yang3Sha Li4Yongsheng Li5Chongqing University Cancer HospitalChongqing University Cancer HospitalChongqing University Cancer HospitalChongqing University Cancer HospitalChongqing University Cancer HospitalChongqing University Cancer HospitalThe investigation of therapeutic cancer vaccines has been ongoing for the past century. Herein, we used VOSviewer and CiteSpace to perform the first global bibliometric analysis of the literature on therapeutic cancer vaccines from 2013 to 2022 aiming to explore the current status and potential research trends. The findings revealed a consistent upward trend in both publication counts and citations. The United States emerged as the leading contributor with the highest number of published papers. Additionally, the analysis of references and keywords indicated that therapeutic cancer vaccines have long been popular topics, whereas neoantigen vaccines, mRNA vaccines, combination strategies, and vaccine delivery systems are emerging research hotspots. This bibliometric study provides a comprehensive and important overview of the current knowledge and potential developments in therapeutic cancer vaccines from 2013 to 2022, which may serve as a valuable reference for scholars interested in further exploring this promising field.http://dx.doi.org/10.1080/21645515.2023.2254262therapeutic cancer vaccinebibliometric analysisimmunotherapyknowledge mapvosviewercitespace |
| spellingShingle | Juan Zhao Bin Liao Li Gong Huiyao Yang Sha Li Yongsheng Li Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis Human Vaccines & Immunotherapeutics therapeutic cancer vaccine bibliometric analysis immunotherapy knowledge map vosviewer citespace |
| title | Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis |
| title_full | Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis |
| title_fullStr | Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis |
| title_full_unstemmed | Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis |
| title_short | Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis |
| title_sort | knowledge mapping of therapeutic cancer vaccine from 2013 to 2022 a bibliometric and visual analysis |
| topic | therapeutic cancer vaccine bibliometric analysis immunotherapy knowledge map vosviewer citespace |
| url | http://dx.doi.org/10.1080/21645515.2023.2254262 |
| work_keys_str_mv | AT juanzhao knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis AT binliao knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis AT ligong knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis AT huiyaoyang knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis AT shali knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis AT yongshengli knowledgemappingoftherapeuticcancervaccinefrom2013to2022abibliometricandvisualanalysis |